Cadrenal Therapeutics Inc (CVKD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 4,200 | 1,077 | 973 | 482 | 171 |
| Operating Income | -4,200 | -1,077 | -973 | -482 | -171 |
| Interest Expense | 17 | 56 | 32 | 15 | 5 |
| Other Income | -956 | -3,887 | -21 | 5 | -2 |
| Pre-tax Income | -5,174 | -5,019 | -1,026 | -492 | -177 |
| Net Income Continuous | -5,174 | -5,019 | -1,026 | -492 | -177 |
| Net Income | $-5,174 | $-5,019 | $-1,026 | $-492 | $-177 |
| EPS Basic Total Ops | -7.20 | -9.45 | -1.95 | -1.05 | -0.30 |
| EPS Basic Continuous Ops | -7.20 | -9.53 | -1.91 | -0.96 | -0.35 |
| EPS Diluted Total Ops | -7.20 | -9.45 | -1.95 | -1.05 | -0.30 |
| EPS Diluted Continuous Ops | -7.20 | -9.53 | -1.91 | -0.96 | -0.35 |
| EBITDA(a) | $-4,187 | $-972 | $-954 | $-474 | $-168 |